A bihormonal closed-loop artificial pancreas for type 1 diabetes

Science Translational Medicine

Volumn 2, Issue 27, 2010, Pages

  El khatib, Firas H ^a   Russell, Steven J ^b   Nathan, David M ^b   Sutherlin, Robert G ^b   Damiano, Edward R ^a  

^a Boston University   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN LISPRO; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; DRUG ABSORPTION; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION; ANALOGS AND DERIVATIVES; ARTIFICIAL PANCREAS; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEMS; FEMALE; GLUCAGON; HUMANS; INSULIN; INSULIN LISPRO; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; YOUNG ADULT;

EID: 77952987107     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000619     Document Type: Article

References (24)

1. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N. Engl. J. Med. 329, 977-986 (1993).
2. D. M. Nathan, P. A. Cleary, J. Y. Backlund, S. M. Genuth, J. M. Lachin, T. J. Orchard, P. Raskin, B. Zinman; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643-2653 (2005).
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287, 2563-2569 (2002).
4. American Diabetes Association, Standards of medical care in diabetes-2009. Diabetes Care 32 (Suppl. 1), S13-S61 (2009).
5. Diabetes Control and Complications Trial Research Group, Hypoglycemia in the diabetes control and complications trial. Diabetes 46, 271-286 (1997).
6. G. P. Leese, J. Wang, J. Broomhall, P. Kelly, A. Marsden, W. Morrison, B. M. Frier, A. D. Morris; DARTS/MEMO Collaboration, Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care 26, 1176-1180 (2003).
7. D. B. Petitti, G. J. Klingensmith, R. A. Bell, J. S. Andrews, D. Dabelea, G. Imperatore, S. Marcovina, C. Pihoker, D. Standiford, B. Waitzfelder, E. Mayer-Davis; SEARCH for Diabetes in Youth Study Group, Glycemic control in youth with diabetes: The SEARCH for diabetes in Youth Study. J. Pediatr. 155, 668-672. E3 (2009).
8. B. Zinman, The physiologic replacement of insulin. An elusive goal. N. Engl. J. Med. 321, 363-370 (1989).
9. I. B. Hirsch, D. Armstrong, R. M. Bergenstal, B. Buckingham, B. P. Childs, W. L. Clarke, A. Peters, H. Wolpert, Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol. Ther. 10, 232-244 (2008).
10. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; W. V. Tamborlane, R. W. Beck, B. W. Bode, B. Buckingham, H. P. Chase, R. Clemons, R. Fiallo-Scharer, L. A. Fox, L. K. Gilliam, I. B. Hirsch, E. S. Huang, C. Kollman, A. J. Kowalski, L. Laffel, J. M. Lawrence, J. Lee, N. Mauras, M. O'Grady, K. J. Ruedy, M. Tansey, E. Tsalikian, S. Weinzimer, D. M. Wilson, H. Wolpert, T. Wysocki, D. Xing, Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 359, 1464-1476 (2008).
11. A. D. Cherrington, Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48, 1198-1214 (1999).
12. G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, M. F. Saad, Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55, 3344-3350 (2006).
13. S. A. Weinzimer, G. M. Steil, K. L. Swan, J. Dziura, N. Kurtz, W. V. Tamborlane, Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 31, 934-939 (2008).
14. W. L. Clarke, S. Anderson, M. Breton, S. Patek, L. Kashmer, B. Kovatchev, Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: The Virginia experience. J. Diabetes Sci. Technol. 3, 1031-1038 (2009).
15. D. Bruttomesso, A. Farret, S. Costa, M. C. Marescotti, M. Vettore, A. Avogaro, A. Tiengo, C. DallaMan, J. Place, A. Facchinetti, S. Guerra, L. Magni, G. De Nicolao, C. Cobelli, E. Renard, A. Maran, Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: Preliminary studies in Padova and Montpellier. J. Diabetes Sci. Technol. 3, 1014-1021 (2009).
16. R. Havorka, J. M. Allen, D. Elleri, L. J. Chassin, J. Harris, D. Xing, C. Kollman, T. Hovorka, A. M. Larsen, M. Nodale, A. De Palma, M. E. Wilinska, C. L. Acerini, D. B. Dunger, Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet 375, 743-751 (2010).
17. F. H. El-Khatib, J. Jiang, E. R. Damiano, A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine. J. Diabetes Sci. Technol. 3, 789-803 (2009).
18. F. H. El-Khatib, J. Jiang, E. R. Damiano, Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine. J. Diabetes Sci. Technol. 1, 181-192 (2007).
19. F. H. El-Khatib, E. R. Damiano, A fully automated control system for type 1 diabetes (Pending U. S. And International Application. Priority date May 15, 2005).
20. E. Renard, J. Place, M. Cantwell, H. Chevassus, C. C. Palerm, Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: Feasibility study testing a new model for the artificial pancreas. Diabetes Care 33, 121-127 (2010).
21. F. H. El-Khatib, J. Jiang, R. G. Gerrity, E. R. Damiano, Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic swine model in vivo. Diabetes Technol. Ther. 9, 135-144 (2007).
22. International Organization for Standardization 15197: 2003, http://www.iso.org/iso/catalogue-detail.htm?csnumber=26309 (accessed 30 August 2009).
23. D. M. Nathan, D. E. Singer, K. Hurxthal, J. D. Goodson, The clinical information value of the glycosylated hemoglobin assay. N. Engl. J. Med. 310, 341-346 (1984).
24. D. M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, R. J. Heine; A1c-Derived Average Glucose Study Group, Translating the A1C assay into estimated average glucose values. Diabetes Care 31, 1473-1478 (2008).